-
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells
Zhang, L., Atencia Taboada, L., Baglamis, S., de Kroon, M., Elshout, C., Ramesh, P., Helderman, R. F. C. P. A., Torang, A., Cameron, K., van Driel, M. S., Wouters, V. M., van Neerven, S. M. & Medema, J. P., 1 Dec 2025, In: Oncogenesis. 14, 1, 25.Research output: Contribution to journal › Article* › Academic › peer-review
-
Pleiotropic role of NOTUM in colorectal cancer
van Driel, M. S., Linssen, J. D. G., van Neerven, S. M. & Vermeulen, L., 1 Dec 2023, In: Gut. 72, 12, p. 2222-2223 2 p., gutjnl-2023-330807.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Caffeine Limits Expansion of Apc-Deficient Clones in the Intestine by NOTUM Inhibition
van Driel, M. S., Linssen, J. D. G., Flanagan, D. J., Vlahov, N., Nijman, L. E., de Groot, N. E., Elbers, C. C., Koster, J., Sansom, O. J., Vermeulen, L. & van Neerven, S. M., Jan 2023, In: Cellular and molecular gastroenterology and hepatology. 16, 4, p. 652-655 4 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications